Inhaltsbereich
| 25 Einträge | 1, 2 › » |
Seite 1 / 2
 Druckansicht
|
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
| Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| PMID: 29146401 |
| Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. |
| Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O |
| Immunity. 2015 Feb 10. pii: S1074-7613(15)00036-9. doi: 10.1016/j.immuni.2015.01.010. pmc: PMC4361732. mid: EMS62361 |
| PMID: 25680274 |
| Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy. |
| Harmankaya K, Erasim C, Koelblinger C, Ibrahim R, Hoos A, Pehamberger H, Binder M |
| Medical oncology (Northwood, London, England). 2010 Jul 1. doi: 10.1007/s12032-010-9606-0 |
| PMID: 20593249 |
| Antitumor response and new lesions in advanced melanoma patients on ipilimumab treatment. |
| Wolchok JD, Ibrahim R, DePril V, Maio M, Queirolo P, Harmankaya K, Lundgren L, Hoos A, Humphrey R, Hamid O |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.3020 |
| PMID: 27947620 |
| Novel efficacy criteria for antitumor activity to immunotherapy using the example of ipilimumab, an anti-CTLA-4 monoclonal antibody. |
| Hodi FS, Hoos A, Ibrahim R, Chin K, Pehamberger H, Harmankaya K, O'Day S, Hamid O, Humphrey R, Wolchok J |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.3008 |
| PMID: 27947617 |
| Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. |
| Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A |
| The European respiratory journal. 2017 Aug 31. pii: 50/2/1700936. doi: 10.1183/13993003.00936-2017 |
| PMID: 28860269 |
| Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial. |
| Carlino MS, Long GV, Schadendorf D, Robert C, Ribas A, Richtig E, Nyakas M, Caglevic C, Tarhini A, Blank C, Hoeller C, Bar-Sela G, Barrow C, Wolter P, Zhou H, Emancipator K, Jensen EH, Ebbinghaus S, Ibrahim N, Daud A |
| European journal of cancer (Oxford, England : 1990). 2018 Aug 7. pii: S0959-8049(18)30948-1. doi: 10.1016/j.ejca.2018.06.034 |
| PMID: 30096704 |
| Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. |
| Hamid O, Robert C, Ribas A, Hodi FS, Walpole E, Daud A, Arance AS, Brown E, Hoeller C, Mortier L, Schachter J, Long J, Ebbinghaus S, Ibrahim N, Butler M |
| British journal of cancer. 2018 Sep 11. doi: 10.1038/s41416-018-0207-6. pii: 10.1038/s41416-018-0207-6 |
| PMID: 30202085 |
| Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis. |
| Cassese S, Wolf F, Ingwersen M, Kinstner CM, Fusaro M, Ndrepepa G, Ibrahim T, Ott I, Lammer J, Krankenberg H, Fusaro M |
| Circulation. Cardiovascular interventions. doi: 10.1161/CIRCINTERVENTIONS.118.007055 |
| PMID: 30562083 |
| Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer. |
| Canonici A, Browne AL, Ibrahim MFK, Fanning KP, Roche S, Conlon NT, O'Neill F, Meiller J, Cremona M, Morgan C, Hennessy BT, Eustace AJ, Solca F, O'Donovan N, Crown J |
| Therapeutic advances in medical oncology. 2020 Jan 28. doi: 10.1177/1758835919897546. pii: 10.1177_1758835919897546. pmc: PMC6987485 |
| PMID: 32064003 |
| Efficacy of lenvatinib in patients with advanced pancreatic (panNETs) and gastrointestinal (giNETs) grade 1/2 (G1/G2) neuroendocrine tumors: Results of the international phase II TALENT trial (GETNE 1509). |
| Capdevila J, Fazio N, Lopez C, Teule A, Valle JW, Tafuto S, Custodio A, Reed N, Raderer M, Grande E, Garcia-Carbonero R, Jimenez Fonseca P, Alonso V, Antonuzzo L, Spallanzani A, Berruti A, Sevilla Garcia I, La Casta A, Hernando J, Ibrahim T |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)49922-5. doi: 10.1093/annonc/mdy293 |
| PMID: 32137197 |
| Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. |
| O'Day SJ, Maio M, Chiarion-Sileni V, Gajewski TF, Pehamberger H, Bondarenko IN, Queirolo P, Lundgren L, Mikhailov S, Roman L, Verschraegen C, Humphrey R, Ibrahim R, de Pril V, Hoos A, Wolchok JD |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2010 Feb 10. pii: S0923-7534(19)39410-4. doi: 10.1093/annonc/mdq013 |
| PMID: 20147741 |
| Catching Common Cold Virus with a Net: Pyridostatin Forms Filaments in Tris Buffer That Trap Viruses-A Novel Antiviral Strategy? |
| Real-Hohn A, Zhu R, Ganjian H, Ibrahim N, Hinterdorfer P, Kowalski H, Blaas D |
| Viruses. 2020 Jul 4. pii: v12070723. doi: 10.3390/v12070723 |
| PMID: 32635420 |
| Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study. |
| Jones E, Hummerich H, Viré E, Uphill J, Dimitriadis A, Speedy H, Campbell T, Norsworthy P, Quinn L, Whitfield J, Linehan J, Jaunmuktane Z, Brandner S, Jat P, Nihat A, How Mok T, Ahmed P, Collins S, Stehmann C, Sarros S, Kovacs GG, Geschwind MD, Golubjatnikov A, Frontzek K, Budka H, Aguzzi A, Karamujić-Čomić H, van der Lee SJ, Ibrahim-Verbaas CA, van Duijn CM, Sikorska B, Golanska E, Liberski PP, Calero M, Calero O, Sanchez-Juan P, Salas A, Martinón-Torres F, Bouaziz-Amar E, Haïk S, Laplanche JL, Brandel JP, Amouyel P, Lambert JC, Parchi P, Bartoletti-Stella A, Capellari S, Poleggi A, Ladogana A, Pocchiari M, Aneli S, Matullo G, Knight R, Zafar S, Zerr I, Booth S, Coulthart MB, Jansen GH, Glisic K, Blevins J, Gambetti P, Safar J, Appleby B, Collinge J, Mead S |
| The Lancet. Neurology. pii: S1474-4422(20)30273-8. doi: 10.1016/S1474-4422(20)30273-8 |
| PMID: 32949544 |
| Selective whole genome amplification of Plasmodium malariae DNA from clinical samples reveals insights into population structure. |
| Ibrahim A, Diez Benavente E, Nolder D, Proux S, Higgins M, Muwanguzi J, Gomez Gonzalez PJ, Fuehrer HP, Roper C, Nosten F, Sutherland C, Clark TG, Campino S |
| Scientific reports. 2020 Jul 2. doi: 10.1038/s41598-020-67568-4. pii: 10.1038/s41598-020-67568-4. pmc: PMC7331648 |
| PMID: 32616738 |
| Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study. |
| Partelli S, Ramage JK, Massironi S, Zerbi A, Kim HB, Niccoli P, Panzuto F, Landoni L, Tomazic A, Ibrahim T, Kaltsas G, Bertani E, Sauvanet A, Segelov E, Caplin M, Coppa J, Armstrong T, Weickert MO, Butturini G, Staettner S, Boesch F, Cives M, Moulton CA, He J, Selberherr A, Twito O, Castaldi A, De Angelis CG, Gaujoux S, Almeamar H, Frilling A, Vigia E, Wilson C, Muffatti F, Srirajaskanthan R, Invernizzi P, Lania A, Kwon W, Ewald J, Rinzivillo M, Nessi C, Smid LM, Gardini A, Tsoli M, Picardi EE, Hentic O, Croagh D, Toumpanakis C, Citterio D, Ramsey E, Mosterman B, Regi P, Gasteiger S, Rossi RE, Smiroldo V, Jang JY, Falconi M |
| Frontiers in medicine. 2020 Dec 23. doi: 10.3389/fmed.2020.598438. pmc: PMC7785972 |
| PMID: 33425946 |
| Histone citrullination as a novel biomarker and target to inhibit progression of abdominal aortic aneurysms. |
| Eilenberg W, Zagrapan B, Bleichert S, Ibrahim N, Knöbl V, Brandau A, Martelanz L, Grasl MT, Hayden H, Nawrozi P, Rajic R, Häusler C, Potolidis A, Schirwani N, Scheuba A, Klopf J, Teubenbacher P, Weigl MP, Kirchweger P, Beitzke D, Stiglbauer-Tscholakoff A, Panzenböck A, Lang I, Mauracher LM, Hell L, Pabinger I, Bailey MA, Scott DJA, Maegdefessel L, Busch A, Huk I, Neumayer C, Brostjan C |
| Translational research : the journal of laboratory and clinical medicine. 2021 Feb 9. pii: S1931-5244(21)00026-8. doi: 10.1016/j.trsl.2021.02.003 |
| PMID: 33571683 |
| Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509). |
| Capdevila J, Fazio N, Lopez C, Teulé A, Valle JW, Tafuto S, Custodio A, Reed N, Raderer M, Grande E, Garcia-Carbonero R, Jimenez-Fonseca P, Hernando J, Bongiovanni A, Spada F, Alonso V, Antonuzzo L, Spallanzani A, Berruti A, La Casta A, Sevilla I, Kump P, Giuffrida D, Merino X, Trejo L, Gajate P, Matos I, Lamarca A, Ibrahim T |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 May 4. doi: 10.1200/JCO.20.03368 |
| PMID: 33945297 |
| Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. |
| Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A, Potenza MN, Ekhtiari H, Baldacchino AM |
| Frontiers in psychiatry. 2021 Apr 29. doi: 10.3389/fpsyt.2021.639393. pmc: PMC8135096 |
| PMID: 34025471 |
| Detecting adulteration of stingless bee honey using untargeted H NMR metabolomics with chemometrics. |
| Yong CH, Muhammad SA, Aziz FA, Nasir FI, Mustafa MZ, Ibrahim B, Kelly SD, Cannavan A, Seow EK |
| Food chemistry. 2021 Aug 9. pii: S0308-8146(21)01814-8. doi: 10.1016/j.foodchem.2021.130808 |
| PMID: 34419793 |
| 25 Einträge | 1, 2 › » |
Seite 1 / 2
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
